NL-OMON32054尚未招募不适用
Azathioprine maintenance treatment versus Infliximab maintenance treatment in Crohn's disease patients in remission - Azorix trial
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 128
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- age > 18
- •- At least 6 months a stable dose of combination therapy with IFX and AZA or with AZA and 6MP
- •- Crohn's Disease in remission (defined by a CDAI lower than 150 points) for at least 6 months
排除标准
- •- Abdominal abscesses, fistulas and fluid collections
- •- Co morbidity or extra-intestinal complications that require infliximab treatment
- •- Crohn's disease activity of the upper gastrointestinal tract that requires infliximab treatment
- •- Age > 80 years
- •- Legally incompetent patients
研究者
相似试验
进行中（未招募）
不适用
Azathioprine maintenance treatment versus Infliximab maintenance treatment in Crohn's disease patients in remission: a randomized multicenter trial - Azorix-trialEUCTR2008-001131-35-NLAcademic Medical Center, department of Gastroenterology and hepatology
招募中
不适用
Azathioprine maintenance treatment versus infliximab maintenance treatment in Crohn’s disease patients in remission (Azorix trial)Crohn´s disease in remissionNL-OMON21255Academic Medical Center (AMC)130
尚未招募
3 期
Azathioprine effect in severe asthmatic patientsIRCT20231219060463N1Ahvaz University of Medical Sciences40
进行中（未招募）
1 期
Can suppressing the immune system with azathioprine slow down the progression of Parkinson's disease?Parkinson's diseaseMedDRA version: 20.0Level: PTClassification code 10061536Term: Parkinson's diseaseSystem Organ Class: 10029205 - Nervous system disordersEUCTR2018-003089-14-GBCambridge University Hospitals NHS Foundation Trust and University of Cambridge60
尚未招募
2 期
Improving Tuberculous Meningitis Care: Testing the Safety and Effectiveness of Azathioprine in Managing Paradoxical Reactions - A Patient-Focused StudyCTRI/2023/12/060448Department of Neurology King George Medical University